- Home
- ATNI vs CYRX Comparison
ATNI vs CYRX Comparison
Compare ATNI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATNI | CYRX |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.7M | 419.3M |
| IPO Year | 1994 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ATNI | CYRX |
|---|---|---|
| Price | $24.33 | $15.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 71.9K | ★ 876.3K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | 34.29 | ★ 156.22 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $727,975,000.00 | $176,177,000.00 |
| Revenue This Year | $3.12 | $11.06 |
| Revenue Next Year | $1.10 | $8.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.86 | $6.69 |
| 52 Week High | $30.45 | $16.73 |
Technical Indicators
Market Signals| Indicator | ATNI | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 56.89 |
| Support Level | $23.18 | $9.28 |
| Resistance Level | $28.38 | $16.73 |
| Average True Range (ATR) | 1.31 | 0.66 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 9.80 | 52.34 |
Price Performance
Historical ComparisonAbout ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.